Akin et al. [67] reported correlations between serum chemerin concentrations and several clinical factors such as diabetes, age of diagnosis, BMI, hypertension, and menopause, but found no significant difference between serum chemerin levels in breast cancer patients with metastatic and non-metastatic cancer (Table 1). Here, RARRES2 is linked to breast cancer.